CSW

SEC source: 0001624794-20-000054 · wf-form4_159017331843293.xml · derivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,279

Underlying: Common Stock · 7,279 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's total shareholder return relative to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's total shareholder return relative to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's total shareholder return relative to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

SEC source: 0001624794-20-000046 · wf-form4_158989732649980.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,075

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

SEC source: 0001624794-20-000041 · wf-form4_158860848552359.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,333

F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund.

SEC source: 0001624794-20-000031 · wf-form4_158698849695414.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,575

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001624794-20-000026 · wf-form4_158621243165371.xml · derivative · entry 4

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,595

Underlying: Common Stock · 3,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001624794-20-000026 · wf-form4_158621243165371.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,808

SEC source: 0001624794-20-000026 · wf-form4_158621243165371.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,186

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001624794-20-000029 · wf-form4_158621249273566.xml · derivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,260

Underlying: Common Stock · 19,359 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F3 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F3 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001624794-20-000029 · wf-form4_158621249273566.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,075

F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund.

SEC source: 0001624794-20-000029 · wf-form4_158621249273566.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,275

SEC source: 0001624794-20-000029 · wf-form4_158621249273566.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001624794-20-000030 · wf-form4_158621251331955.xml · derivative · entry 4

Branning Greggory W · CIK 0001557808 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,812

Underlying: Common Stock · 5,531 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on each of March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on each of March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on each of March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001624794-20-000030 · wf-form4_158621251331955.xml · nonDerivative · entry 2

Branning Greggory W · CIK 0001557808 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,727.715

SEC source: 0001624794-20-000030 · wf-form4_158621251331955.xml · nonDerivative · entry 1

Branning Greggory W · CIK 0001557808 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,128.715

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001624794-20-000028 · wf-form4_158621247246674.xml · derivative · entry 4

Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,098

Underlying: Common Stock · 3,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001624794-20-000028 · wf-form4_158621247246674.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,448

SEC source: 0001624794-20-000028 · wf-form4_158621247246674.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,813

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001624794-20-000027 · wf-form4_158621245180205.xml · derivative · entry 4

Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,571

Underlying: Common Stock · 1,970 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2020 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001624794-20-000027 · wf-form4_158621245180205.xml · nonDerivative · entry 2

Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,218

SEC source: 0001624794-20-000027 · wf-form4_158621245180205.xml · nonDerivative · entry 1

Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,787

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001624794-20-000026 · wf-form4_158621243165371.xml · derivative · entry 3

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,595

Underlying: Common Stock · 2,273 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

SEC source: 0001624794-20-000029 · wf-form4_158621249273566.xml · derivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,619

Underlying: Common Stock · 12,333 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

SEC source: 0001624794-20-000030 · wf-form4_158621251331955.xml · derivative · entry 3

Branning Greggory W · CIK 0001557808 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,343

Underlying: Common Stock · 3,869 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

SEC source: 0001624794-20-000028 · wf-form4_158621247246674.xml · derivative · entry 3

Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,098

Underlying: Common Stock · 3,945 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

SEC source: 0001624794-20-000027 · wf-form4_158621245180205.xml · derivative · entry 3

Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,541

Underlying: Common Stock · 2,516 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2020 and ending on March 31, 2023 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

SEC source: 0001624794-20-000025 · wf-form4_158448603003958.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,576

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

SEC source: 0001624794-20-000023 · wf-form4_158439842482570.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,380

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001624794-20-000022 · wf-form4_158410530203905.xml · nonDerivative · entry 1

von Storch Debra · CIK 0001797025 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,825

SEC source: 0001624794-20-000020 · wf-form4_158206689320009.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,076

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.44 to $74.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001624794-20-000012 · wf-form4_157912599738149.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,576

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.73 to $78.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001624794-20-000008 · wf-form4_157800511031747.xml · nonDerivative · entry 1

von Storch Debra · CIK 0001797025 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,825

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on October 1, 2020.

SEC source: 0001624794-19-000078 · wf-form4_157653834742576.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,076

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.07 to $77.91, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001624794-19-000077 · wf-form4_157411149537180.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,576

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F3 · acquired: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.10 to $75.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001624794-19-000077 · wf-form4_157411149537180.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,715

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · acquired: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.34 to $76.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001624794-19-000061 · wf-form4_157005346640454.xml · nonDerivative · entry 1

QUINN WILLIAM F · CIK 0001035219 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,698

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

SEC source: 0001624794-19-000060 · wf-form4_157005344133377.xml · nonDerivative · entry 1

Sweezey Jay Kent · CIK 0001691674 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,116

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

SEC source: 0001624794-19-000067 · wf-form4_157005362160330.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,136

SEC source: 0001624794-19-000067 · wf-form4_157005362160330.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,094

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001624794-19-000066 · wf-form4_157005359518489.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,576

SEC source: 0001624794-19-000066 · wf-form4_157005359518489.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,289

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001624794-19-000057 · wf-form4_157005336459436.xml · nonDerivative · entry 1

Swartz Robert M · CIK 0001413221 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,309

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

SEC source: 0001624794-19-000064 · wf-form4_157005354567265.xml · nonDerivative · entry 1

GAMBRELL MICHAEL R · CIK 0001277031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,308

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

SEC source: 0001624794-19-000059 · wf-form4_157005341593038.xml · nonDerivative · entry 2

Branning Greggory W · CIK 0001557808 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,976.715

SEC source: 0001624794-19-000059 · wf-form4_157005341593038.xml · nonDerivative · entry 1

Branning Greggory W · CIK 0001557808 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,962.715

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001624794-19-000062 · wf-form4_157005349272248.xml · nonDerivative · entry 1

JOHNSTON TERRY L · CIK 0001565364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,882

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

SEC source: 0001624794-19-000065 · wf-form4_157005357080994.xml · nonDerivative · entry 1

LIVINGSTONE LINDA A. · CIK 0001652531 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,308

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

SEC source: 0001624794-19-000063 · wf-form4_157005351814864.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,763

SEC source: 0001624794-19-000063 · wf-form4_157005351814864.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · SVP & GM, Ind. Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,095

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001624794-19-000058 · wf-form4_157005339028742.xml · nonDerivative · entry 2

Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,813

SEC source: 0001624794-19-000058 · wf-form4_157005339028742.xml · nonDerivative · entry 1

Foster Craig James · CIK 0001663184 · SVP & GM, Spec. Chem.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,594

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.